Board Member
Aura Biosciences, Inc. (AURA)Equibles does not estimate personal net worth.
Get an email with a short summary when Aura Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get AURA alertsNatalie Holles is recorded as CEO and Board Member at Aura Biosciences, Inc. (AURA) since April 30, 2026. Aura Biosciences, Inc. reported in an 8-K filed May 4, 2026 that Natalie Holles was appointed Class I director, effective April 30, 2026. Aura Biosciences, Inc. reported in an 8-K filed May 4, 2026 that Natalie Holles was appointed Chief Executive Officer and President, effective April 30, 2026. Natalie Holles has spoken on 1 earnings call across 1 company, most recently for Aura Biosciences, Inc. on May 27, 2026. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Elisabet de los Pinos (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer), Anthony Gibney (CFO) and 7 others.
“On April 29, 2026, the Board of Directors (the "Board") of Aura Biosciences, Inc. (the "Company") appointed Natalie Holles as the Company's Chief Executive Officer and President and as a Class I director with a term expiring at the Company's 2028 annual meeting of stockholders, effective as of April 30, 2026 (the "Effective Date").”
“On April 29, 2026, the Board of Directors (the "Board") of Aura Biosciences, Inc. (the "Company") appointed Natalie Holles as the Company's Chief Executive Officer and President and as a Class I director with a term expiring at the Company's 2028 annual meeting of stockholders, effective as of April 30, 2026 (the "Effective Date").”
“Certainly, and thanks for having me here, Phil. And I'm delighted to chat about Aura and my awesome new job I'm very excited about. So what attracted me to Aura, this was a unique opportunity.”
2026-04-30–present
2026-04-30–present
Biotechnology · Healthcare
CEO, Board Member
2026-04-30–present
